company background image
AMES

Alexandria New Medical CenterCASE:AMES Stock Report

Market Cap

ج.م849.3m

7D

0%

1Y

65.9%

Updated

22 Oct, 2021

Data

Company Financials
AMES fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

AMES Overview

Alexandria New Medical Center engages in the operation of a hospital in Egypt.

Price History & Performance

Summary of all time highs, changes and price drops for Alexandria New Medical Center
Historical stock prices
Current Share Priceج.م54.54
52 Week Highج.م22.08
52 Week Lowج.م65.31
Beta-0.52
1 Month Change0%
3 Month Change-5.53%
1 Year Change65.87%
3 Year Change235.36%
5 Year Change213.25%
Change since IPO1,664.24%

Recent News & Updates

Shareholder Returns

AMESEG HealthcareEG Market
7D0%1.3%-0.8%
1Y65.9%-14.9%11.1%

Return vs Industry: AMES exceeded the EG Healthcare industry which returned -14.9% over the past year.

Return vs Market: AMES exceeded the EG Market which returned 11.1% over the past year.

Price Volatility

Is AMES's price volatile compared to industry and market?
AMES volatility
AMES Beta-0.52
Industry Beta0.39
Market Beta1

Stable Share Price: AMES is less volatile than 75% of EG stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: AMES's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1988n/aBavaguthu Shettyhttps://www.anmchosp.com

Alexandria New Medical Center engages in the operation of a hospital in Egypt. The company’s hospital provides range of medical specialization services, including gynecology, general surgery, pediatrics, and other, as well as medical diagnostic and treatment services in various medical fields. It also operates children’s, brain and nerve disease, sugar, liver, chest, cardiology, internal, oncology, dental, nose and ear, women’s, ophthalmology, nutrition, dermatology, blood disease, and rheumatology clinics; specialized units and centers; and dormitories.

Alexandria New Medical Center Fundamentals Summary

How do Alexandria New Medical Center's earnings and revenue compare to its market cap?
AMES fundamental statistics
Market Capج.م849.34m
Earnings (TTM)ج.م26.28m
Revenue (TTM)ج.م235.45m

32.3x

P/E Ratio

3.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AMES income statement (TTM)
Revenueج.م235.45m
Cost of Revenueج.م151.91m
Gross Profitج.م83.54m
Expensesج.م57.27m
Earningsج.م26.28m

Last Reported Earnings

Mar 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)1.69
Gross Margin35.48%
Net Profit Margin11.16%
Debt/Equity Ratio14.9%

How did AMES perform over the long term?

See historical performance and comparison

Valuation

Is Alexandria New Medical Center undervalued compared to its fair value and its price relative to the market?

32.32x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: AMES (EGP54.54) is trading above our estimate of fair value (EGP15.19)

Significantly Below Fair Value: AMES is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: AMES's PE Ratio (32.3x) is in line with the African Healthcare industry average.

PE vs Market: AMES is poor value based on its PE Ratio (32.3x) compared to the EG market (11.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AMES's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AMES is overvalued based on its PB Ratio (3.6x) compared to the XF Healthcare industry average (2.8x).


Future Growth

How is Alexandria New Medical Center forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

15.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Alexandria New Medical Center has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Alexandria New Medical Center performed over the past 5 years?

11.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AMES has high quality earnings.

Growing Profit Margin: AMES's current net profit margins (11.2%) are higher than last year (10.6%).


Past Earnings Growth Analysis

Earnings Trend: AMES's earnings have grown by 11.1% per year over the past 5 years.

Accelerating Growth: AMES's earnings growth over the past year (13.7%) exceeds its 5-year average (11.1% per year).

Earnings vs Industry: AMES earnings growth over the past year (13.7%) exceeded the Healthcare industry 4.5%.


Return on Equity

High ROE: AMES's Return on Equity (11.9%) is considered low.


Financial Health

How is Alexandria New Medical Center's financial position?


Financial Position Analysis

Short Term Liabilities: AMES's short term assets (EGP170.6M) exceed its short term liabilities (EGP83.2M).

Long Term Liabilities: AMES's short term assets (EGP170.6M) exceed its long term liabilities (EGP8.1M).


Debt to Equity History and Analysis

Debt Level: AMES's debt to equity ratio (14.9%) is considered satisfactory.

Reducing Debt: AMES's debt to equity ratio has reduced from 19.3% to 14.9% over the past 5 years.

Debt Coverage: AMES's debt is well covered by operating cash flow (98%).

Interest Coverage: AMES's interest payments on its debt are well covered by EBIT (15.9x coverage).


Balance Sheet


Dividend

What is Alexandria New Medical Center current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AMES's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AMES's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AMES's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AMES's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AMES's dividend in 3 years as they are not forecast to pay a notable one for the EG market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Bavaguthu Shetty (78 yo)

no data

Tenure

Dr. Bavaguthu Raghuram Shetty is the Founder and Chief Executive Officer at BR Healthcare Suites. Dr. Shetty is the Founding Partner, Chief Executive Officer and Managing Director at New Medical Centre Hos...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Alexandria New Medical Center's employee growth, exchange listings and data sources


Key Information

  • Name: Alexandria New Medical Center
  • Ticker: AMES
  • Exchange: CASE
  • Founded: 1988
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: ج.م849.335m
  • Shares outstanding: 15.57m
  • Website: https://www.anmchosp.com

Location

  • Alexandria New Medical Center
  • May 14 Road
  • Smouha
  • Alexandria
  • Egypt

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/22 14:31
End of Day Share Price2021/10/20 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.